Compounded vs FDA-approved · US self-pay prices

Compounded semaglutide vs Ozempic

Ozempic is FDA-approved semaglutide made by Novo Nordisk; compounded semaglutide is made by compounding pharmacies and is not FDA-approved. At the starting dose, the lowest self-pay prices are ≈ $213 per 30 days for Ozempic injection, $199/fill initially at NovoCare (Novo Nordisk); $149 per 30 days for Ozempic tablet, $149/30 days at NovoCare (Novo Nordisk). The lowest compounded semaglutide price that states its supply is ≈ $103 per 30 days: $96.05/28 days at Affinity Direct, on a 3-month plan paid upfront.

Ozempic

FDA-approved · Novo Nordisk

Injection

Lowest self-pay, starting dose

$199/fill initially

28-day supply

≈ $213.21 per 30 days at this quoted rate

Offer through

Checked

Ozempic pen

NovoCare (Novo Nordisk) · Manufacturer direct

first two monthly fills at 0.25 or 0.5 mg for new patients, prescribed by Dec 31, 2026

Price conditions

first two monthly fills at 0.25 or 0.5 mg for new patients, prescribed by Dec 31, 2026

After the introductory offer: $349 per monthly fill for 0.25, 0.5, or 1 mg; $499 for 2 mg. NovoCare defines one injection fill as a 28-day supply. Eligibility and restrictions apply.

28-day supply

Tablet

Lowest self-pay, starting dose

$149/30 days

30-day supply

$149 per 30 days at this quoted rate

Checked

Ozempic tablets

NovoCare (Novo Nordisk) · Manufacturer direct

self-pay, 1.5 mg starting dose

Price conditions

self-pay, 1.5 mg starting dose

A prescription is required. The 1.5 mg initiation dose costs $149 for 30 tablets. Self-pay purchases are processed outside insurance and do not count toward deductibles or out-of-pocket limits. Ozempic tablet prices are separate from Wegovy tablet prices.

30-day supply

Compounded semaglutide

Not FDA-approved · 32 sellers

Lowest with a stated supply

$96.05/28 days

28-day supply · 3-month upfront payment required

≈ $102.91 per 30 days at this quoted rate

Checked

Compounded semaglutide via Affinity Direct

Affinity Direct · Sourced provider quote

3-month starter pack (0.25, then 0.5, then 1 mg weekly) on auto-refill, billed $288.15 every 12 weeks, the same price at each reorder; a single 4-week supply bought one time is $169 to $199 by dose; medication, provider review, injection supplies and cold shipping included; no membership fee

Price conditions

3-month starter pack (0.25, then 0.5, then 1 mg weekly) on auto-refill, billed $288.15 every 12 weeks, the same price at each reorder; a single 4-week supply bought one time is $169 to $199 by dose; medication, provider review, injection supplies and cold shipping included; no membership fee

Each weekly dose is priced separately: one-time 4-week supplies run $169 (0.25 mg) to $199 (2.4 mg), and auto-refill takes 15% off. Auto-refill is optional and can be cancelled at any time; a full refund is given if the provider does not prescribe. Ships to all 50 states. Compounded; not FDA-approved.

28-day supply · 3-month upfront payment required

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a product or a dose. Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.

Side by side

Ozempic and compounded semaglutide compared

The same active ingredient, two different products. Prices are the sellers' own; the full lists are on each price page.

Compounded semaglutide vs Ozempic: FDA status, approved uses, prices and trial results
CompareOzempicCompounded semaglutide
What it isFDA-approved semaglutide made by Novo Nordisk.Semaglutide made by compounding pharmacies. Not FDA-approved, and not a generic of Ozempic.
FDA reviewReviewed and approved by the FDA for the uses on its label.Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. The FDA had received 990 reports of adverse events associated with compounded semaglutide as of May 31, 2026.
Approved for
  • Injection: Adults with type 2 diabetes: glucose control; cardiovascular risk reduction with established cardiovascular disease; kidney and cardiovascular protection with chronic kidney disease.
  • Tablet: Adults with type 2 diabetes: glucose control and cardiovascular risk reduction in those at high risk. The tablet label does not include the injection's kidney indication.
No approved use.
FormsInjection (Once weekly); Tablet (Once daily, on an empty stomach)Injection and tablets, as each seller lists them
Sellers with a price532
Lowest price, starting dose
  • Injection: $199/fill initially at NovoCare (Novo Nordisk), ≈ $213 per 30 days
  • Tablet: $149/30 days at NovoCare (Novo Nordisk), $149 per 30 days
≈ $103 per 30 days at Affinity Direct ($96.05/28 days), the lowest of 8 quotes that state their supply
At the top published dose
  • Injection: $499/28 days at 2 mg, from NovoCare (Novo Nordisk)
  • Tablet: $299/30 days at 9 mg, from NovoCare (Novo Nordisk)
$127.22/28 days at 2.4 mg, from Affinity Direct
Trial resultsSee its labelNone that apply: a brand's trial results are for the brand.

A lower price is not a like-for-like saving. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. It has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide, and says salt forms (such as semaglutide sodium) should not be used to compound it. FDA: concerns with unapproved GLP-1 drugs used for weight loss

Questions

Compounded semaglutide vs Ozempic: common questions

Is compounded semaglutide the same as Ozempic?

No. Both contain semaglutide, but Ozempic is an FDA-approved product made by Novo Nordisk, and compounded semaglutide is made by compounding pharmacies, is not FDA-approved and is not a generic of Ozempic. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. It has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide, and says salt forms (such as semaglutide sodium) should not be used to compound it. FDA: concerns with unapproved GLP-1 drugs used for weight loss

Is compounded semaglutide cheaper than Ozempic?

At the starting dose, the lowest self-pay prices are ≈ $213 per 30 days for Ozempic injection, $199/fill initially at NovoCare (Novo Nordisk); $149 per 30 days for Ozempic tablet, $149/30 days at NovoCare (Novo Nordisk). The lowest compounded semaglutide price that states its supply is ≈ $103 per 30 days: $96.05/28 days at Affinity Direct, on a 3-month plan paid upfront. At the top published dose, ≈ $535 per 30 days for Ozempic injection 2 mg, $499/28 days at NovoCare (Novo Nordisk); $299 per 30 days for Ozempic tablet 9 mg, $299/30 days at NovoCare (Novo Nordisk). The lowest compounded semaglutide top-dose price that states its supply is ≈ $136 per 30 days at 2.4 mg: $127.22/28 days at Affinity Direct, on a 3-month plan paid upfront. 32 sellers publish a price for compounded semaglutide and 5 publish one for Ozempic. They are different products, so a price gap does not make them interchangeable.

Is compounded semaglutide as effective as Ozempic?

Ozempic's approval rests on its own clinical trials. Those results are for Ozempic. The FDA does not review compounded drugs for effectiveness, so they do not carry over to a compounded product.

What is Ozempic approved for?

Injection: Adults with type 2 diabetes: glucose control; cardiovascular risk reduction with established cardiovascular disease; kidney and cardiovascular protection with chronic kidney disease. Tablet: Adults with type 2 diabetes: glucose control and cardiovascular risk reduction in those at high risk. The tablet label does not include the injection's kidney indication.

Can pharmacies still make compounded semaglutide?

The FDA declared the semaglutide shortage resolved in February 2025, which ended the exemption that let pharmacies make copies of the approved drug in bulk. Compounding is now generally limited to patient-specific prescriptions, and the FDA says compounded drugs should only be used for patients whose medical needs an FDA-approved drug cannot meet. No shortage is listed in the latest complete FDA check. The FDA does list discontinuation notices for specific presentations.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.